Some antidepressants can increase libido, though the answer depends heavily on which medication you’re taking and what’s driving your low desire in the first place. Depression itself tanks sexual interest in more than 70% of people with the condition, and many patients report that loss of desire feels worse than their other symptoms. So an antidepressant that effectively lifts depression can restore libido simply by treating the underlying cause. But certain medications go further, actively working through brain pathways that fuel sexual desire rather than suppress it.
Why Most Antidepressants Lower Desire
Two brain chemicals sit at the center of this issue: dopamine and serotonin. Dopamine drives the brain’s reward system, producing the motivation and pleasure that underpin sexual desire. Serotonin, while essential for mood regulation, generally puts the brakes on sexual response when levels spike. The most commonly prescribed antidepressants, SSRIs, work by flooding the brain with more serotonin. That’s great for anxiety and depression, but it directly interferes with the dopamine-driven reward signals that make sex feel appealing and pleasurable.
The numbers are stark. Sexual dysfunction secondary to SSRIs occurs in over 60% of sexually active patients. When studied in healthy volunteers with no depression, the rate climbs above 80%, confirming that this is a direct drug effect rather than a symptom of illness. More than 35% of patients stop taking their antidepressant because of sexual side effects, which makes this far more than a minor inconvenience.
Bupropion: The Clearest Case for Increased Libido
Bupropion stands apart from other antidepressants because it works primarily on dopamine and norepinephrine rather than serotonin. This distinction matters enormously for sexual function. In a pilot study of nondepressed subjects, 70% reported improvement in libido, arousal, or orgasmic function while taking bupropion. That’s not just “less harm” compared to SSRIs. It’s a genuine boost in sexual functioning.
Clinical guidelines back this up. When patients on SSRIs develop low sexual desire, one of the top evidence-based recommendations is either switching to bupropion or adding it alongside the existing antidepressant. Both strategies carry at least moderate scientific evidence for restoring desire. For people who haven’t started treatment yet and are concerned about sexual side effects, bupropion is often a strong first choice.
Mirtazapine and Improved Sexual Life
Mirtazapine works through a different mechanism than SSRIs, blocking certain serotonin receptors rather than broadly increasing serotonin levels. A large observational study tracked sexual function in depressed patients starting mirtazapine and found a dramatic trajectory. At the beginning of the study, 93% reported sexual problems. One month in, that dropped to 61%. By three months, only 27% still had issues, and by the study’s end, just 25% reported problems. Patients also reported increasing frequency of sexual intercourse as treatment progressed.
This pattern reflects both the lifting of depression and the medication’s relatively gentle profile on sexual pathways. Clinical guidelines list mirtazapine alongside bupropion as a recommended switch for patients experiencing low desire on other antidepressants.
Newer Options With Lower Sexual Impact
Vortioxetine, a newer antidepressant, has a more complex mechanism that appears to partially spare sexual function. Its rates of sexual dysfunction range from under 1% to 45% depending on the study and dose, which is a wide spread but still generally better than traditional SSRIs. At doses under 15 milligrams, it carries moderate evidence as an alternative for patients with desire problems. At 20 milligrams, sexual side effects become more common. One notable finding: patients who switched to vortioxetine from an SSRI that was causing sexual problems saw greater improvement in sexual function than those who switched to escitalopram.
Vilazodone, which combines serotonin reuptake inhibition with partial activation of a specific serotonin receptor, shows a mixed but interesting picture. In a phase IV clinical trial, 33 to 39% of women with baseline sexual dysfunction who took vilazodone shifted to normal sexual function during treatment, compared to 27 to 28% on citalopram (a standard SSRI) or placebo. Women in the vilazodone groups also showed marked improvements in orgasm that weren’t seen with citalopram. For men, the results were less clear, with improvements roughly similar across all groups including placebo.
Strategies When Your Current Medication Is the Problem
If you’re already on an SSRI that’s working well for your mood but crushing your desire, several approaches can help without abandoning effective treatment.
- Adding bupropion: This is one of the most well-supported strategies, carrying moderate evidence for restoring desire. It works by supplementing the dopamine activity that SSRIs suppress.
- Switching medications: Moving to agomelatine carries the strongest evidence for resolving low desire. Switching to bupropion, mirtazapine, lower-dose vortioxetine, or desvenlafaxine are also supported options.
- Dose reduction: Lowering the SSRI dose can help, though the evidence is weaker and you risk losing the antidepressant benefit.
- Drug holidays: Skipping medication on two consecutive days (timed before anticipated sexual activity) improved desire in 40 to 60% of women in clinical trials, depending on the specific SSRI. This approach showed no major safety concerns over eight weeks, though mild headaches and agitation occurred in a small percentage. This strategy does not work for fluoxetine, which stays in the body too long for a brief break to matter.
- Adding buspirone: An anti-anxiety medication sometimes used off-label, buspirone showed a 58% improvement rate for sexual dysfunction in one study when added to an SSRI, compared to 30% with placebo. However, a later study found it performed no better than placebo, so the evidence remains uncertain.
The Depression Factor
Here’s the piece that often gets overlooked: untreated depression is itself one of the most potent killers of sexual desire. When more than 70% of depressed people report lost sexual interest before taking any medication, the question shifts. For many people, the right antidepressant doesn’t just avoid harming libido. It restores desire that depression had already taken away. Clinical trial data consistently shows that patients whose depression responds well to treatment see the largest improvements in sexual function, regardless of which medication they’re on.
This means the relationship between antidepressants and libido isn’t a simple equation. A medication that causes some degree of sexual blunting might still leave you with better sexual function overall if it successfully treats severe depression that was already destroying your desire.
What Recovery Looks Like
If you switch medications or stop treatment, sexual side effects from SSRIs ordinarily resolve once the drug clears your system. For most people, this means days to weeks depending on the medication’s half-life. There is, however, a rare condition called post-SSRI sexual dysfunction, in which genital numbness, absent orgasm, or lost libido persist after stopping the medication. This can last months, years, or in some cases decades, though some people experience gradual spontaneous recovery over several years. The condition is not well understood and appears uncommon, but it’s worth being aware of, particularly if sexual function is a high priority for you when choosing a treatment.
The practical takeaway is that your choice of antidepressant matters significantly for sexual function, and there are real options that can preserve or even enhance libido. If sexual side effects are a concern, raising it before starting treatment gives you the best chance of landing on a medication that treats your mood without sacrificing your sex life.